Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer

Daniel Gioeli(University of Virginia), Michael J. Weber(Carter Center)
Molecular Cancer Therapeutics
June 28, 2011
Cited by 66


Related Papers